Morgan Stanley’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5K | Buy |
|
|||||
|
2025
Q1 | $34 | Sell |
|
|||||
|
2024
Q4 | $13.7K | Buy |
|
|||||
|
2024
Q3 | $1.57K | Buy |
|
|||||
|
2024
Q2 | $134 | Sell |
|
|||||
|
2024
Q1 | $274 | Sell |
|
|||||
|
2023
Q4 | $1.68K | Buy |
|
|||||
|
2023
Q3 | $205 | Sell |
|
|||||
|
2023
Q2 | $721 | Buy |
|
|||||
|
2023
Q1 | $1.74K | Sell |
|
|||||
|
2022
Q4 | $62.5K | Buy |
|
|||||
|
2022
Q3 | $195K | Buy |
|
|||||
|
2022
Q2 | $125K | Buy |
|
|||||
|
2022
Q1 | $99K | Buy |
|
|||||
|
2021
Q4 | $92K | Buy |
|
|||||
|
2021
Q3 | $156K | Sell |
|
|||||
|
2021
Q2 | $301K | Buy |
|
|||||
|
2021
Q1 | $137K | Sell |
|
|||||
|
2020
Q4 | $170K | Buy |
|
|||||
|
2020
Q3 | $197K | Buy |
|
|||||
|
2020
Q2 | $21K | Sell |
|
|||||
|
2020
Q1 | $22K | Sell |
|
|||||
|
2019
Q4 | $158K | Sell |
|
|||||
|
2019
Q3 | $266K | Sell |
|
|||||
|
2019
Q2 | $547K | Sell |
|
|||||
|
2019
Q1 | $877K | Buy |
|
|||||
|
2018
Q4 | $462K | Buy |
|
|||||
|
2018
Q3 | $230K | Buy |
|
|||||
|
2018
Q2 | $25K | Buy |
|
|||||
|
2018
Q1 | $9K | Buy |
|
|||||
|
2017
Q4 | $3K | Sell |
|
|||||
|
2017
Q3 | $28K | Sell |
|
|||||
|
2017
Q2 | $42K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $58K | Hold |
|
|||||
|
2016
Q3 | $89K | Buy |
|
|||||
|
2016
Q2 | $11K | Sell |
|
|||||
|
2016
Q1 | $68K | Sell |
|
|||||
|
2015
Q4 | $196K | Buy |
|
|||||
|
2015
Q3 | $10K | Hold |
|
|||||
|
2015
Q2 | $20K | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|
|||||
|
2014
Q3 | – | Hold |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Hold |
|